Modified cap group suberoylanilide hydroxamic acid histone deacetylase inhibitor derivatives reveal improved selective antileukemic activity.
about
Novel (64)Cu-Labeled CUDC-101 for in Vivo PET Imaging of Histone Deacetylases.Potent and orally efficacious bisthiazole-based histone deacetylase inhibitorsThe synthesis and evaluation of N1-(4-(2-[18F]-fluoroethyl)phenyl)-N8-hydroxyoctanediamide ([18F]-FESAHA), a PET radiotracer designed for the delineation of histone deacetylase expression in cancer.Quantitative structure-activity relationship analysis and virtual screening studies for identifying HDAC2 inhibitors from known HDAC bioactive chemical libraries.Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.Vorinostat in acute myeloid leukemia and myelodysplastic syndromes.The structural requirements of histone deacetylase inhibitors: SAHA analogs modified at the C5 position display dual HDAC6/8 selectivity.Metal-Free Synthesis of N-Aryl Amides using Organocatalytic Ring-Opening Aminolysis of Lactones.Perfluorinated HDAC inhibitors as selective anticancer agents.Photoorganocatalytic One-Pot Synthesis of Hydroxamic Acids from Aldehydes.Silyl-mediated photoredox-catalyzed Giese reaction: addition of non-activated alkyl bromidesEngineering Lineage Potency and Plasticity of Stem Cells using Epigenetic Molecules
P2860
Q33635942-002DA177-1046-489E-8968-A4264C742C6DQ33768549-FB2EC200-B182-4FA5-BD1C-000A99E5D503Q35133494-FCB42432-BC79-4762-937A-00384257BC38Q36319273-ECBA5817-287B-4735-A28B-0F7C902FF6D7Q37024770-F1D89C73-9598-49B3-89C6-045302EBE6BDQ37824712-EE7609D7-8715-4CC5-9A37-5555CC92AA57Q38699115-2AB94A9F-86B6-425D-AA6D-9F099F449C7FQ48318078-F31E1FF4-F72D-451F-A830-A800FA2F60CEQ50089128-9A2F98B6-D613-4163-9871-48897A746A22Q50230615-0659255A-B934-41B7-B10E-701C3BA108B5Q57496202-1BF1289E-4F4D-440A-904E-7F17882A83C6Q58618195-7724BEDF-79B2-4152-8776-F340C16C58BB
P2860
Modified cap group suberoylanilide hydroxamic acid histone deacetylase inhibitor derivatives reveal improved selective antileukemic activity.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Modified cap group suberoylani ...... lective antileukemic activity.
@en
Modified cap group suberoylani ...... lective antileukemic activity.
@nl
type
label
Modified cap group suberoylani ...... lective antileukemic activity.
@en
Modified cap group suberoylani ...... lective antileukemic activity.
@nl
prefLabel
Modified cap group suberoylani ...... lective antileukemic activity.
@en
Modified cap group suberoylani ...... lective antileukemic activity.
@nl
P2093
P50
P356
P1476
Modified cap group suberoylani ...... elective antileukemic activity
@en
P2093
Audrey Restouin
Chanaz Salmi-Smail
Franck Dequiedt
Jean Michel Brunel
Rémy Castellano
Slaveia Garbit
P304
P356
10.1021/JM901358Y
P407
P577
2010-04-01T00:00:00Z